#Marijuana-Market analysis

[health-views-updates]

The Evolving Legal Marijuana Market: What to Expect in the Coming Years

Legal Marijuana Market Outlook, Scope & Overview:

Industry reports indicate that the global legal marijuana market was valued at USD 21.08 billion in 2023 and is projected to reach USD 130.55 billion by 2031, growing at a CAGR of 25.6% over the forecast period 2024-2031.

Regulatory Changes and Increasing Acceptance to Drive Growth of Global Legal Marijuana Market

The adoption of legal marijuana for medical and recreational purposes will continue to influence global market revenues. Regulatory changes, increasing acceptance of cannabis use, and rising investments in cannabis cultivation and product development are key factors driving market growth.

As a product segment, medical marijuana currently holds a significant share of the global legal marijuana market. This segment is anticipated to grow at a year-over-year rate of 25.6% in 2024 over 2023 and reach USD 130.55 billion in revenues by 2031. The increasing recognition of marijuana's therapeutic benefits and the growing number of countries legalizing its medical use are expected to drive market growth.

Legal Marijuana Market – Market Dynamics

Drivers:

The legal marijuana market is witnessing significant growth in the global market due to the increasing legalization and decriminalization of cannabis across various regions. The rising acceptance of marijuana for both medical and recreational use, coupled with growing investments in cannabis research and development, are key factors driving the adoption of legal marijuana worldwide. Additionally, the expanding consumer base and the increasing availability of cannabis products through legal channels are further propelling market growth.

Restraints:

Despite the growth potential, challenges such as stringent regulatory requirements, social stigma, and the complexity of cannabis legalization across different regions are hindering the widespread adoption of legal marijuana. Moreover, concerns about potential misuse, the need for standardized dosing and quality control, and the risk of legal and financial uncertainties pose additional challenges to market expansion.

Legal Marijuana Market – Market Outlook

The proven benefits of legal marijuana in treating various medical conditions, improving quality of life, and offering recreational enjoyment have contributed to the market's growth. Legal marijuana is expected to witness increased adoption across major markets, including North America, Europe, and Asia Pacific, driven by favorable regulatory changes and the growing acceptance of cannabis use.

Global Legal Marijuana Market

The rise in demand for legal marijuana in developed and emerging markets is expected to drive market growth over the forecast period. North America currently holds a significant market share in the global legal marijuana market, with the US and Canada being key contributors to market revenues. Europe and Asia Pacific regions are also experiencing rapid adoption of legal marijuana, supported by evolving regulatory frameworks and increasing consumer demand.

Key Players in the Legal Marijuana Market

Leading companies in the legal marijuana market include Canopy Growth Corporation, Aurora Cannabis Inc., Tilray, Inc., and Cronos Group. These companies are at the forefront of developing and commercializing a wide range of cannabis products for medical and recreational use, including flowers, edibles, oils, and concentrates.

In conclusion, the global legal marijuana market is poised for substantial growth over the forecast period, driven by regulatory changes, increasing acceptance of cannabis use, and the expanding adoption of legal marijuana across diverse regions and applications.

Other Trending Reports

Sleep Apnea Devices Market Share by Company

Mammography Workstations Market Share by Company

CMO/CDMO Market Share by Company

Functional Service Providers (FSP) Market Share by Company

[brightlotusmoon]

Marijuana Will Gain Millions Of Consumers Over Alcohol, With Sales Hitting $37 Billion By 2027, Investment Bank Projects

A multinational investment bank says that marijuana has become a “formidable competitor” to alcohol, projecting that nearly 20 million more people will regularly consume cannabis over the next five years as booze loses a couple million drinkers. It also says marijuana sales are estimated to reach $37 billion in 2027 as more state markets come online.

An analysis from the firm TD Cowen says marijuana sales reached $29 billion in 2023, which is approximately 11 percent of what the alcohol industry brought it. That's up from four percent just five years ago, and marijuana is expected to grow by another seven percent annually over the next five years.

“As such, we believe that over the next 5 years, the cannabis category will add 18 million past-month consumers, while alcohol will lose 2 million past-month consumers, as consumers increasingly embrace cannabis and temper their alcohol consumption,” the report, titled “Cannabis Beats Booze,” says.

Vivien Azer, team lead on the analysis, told Marijuana Moment that the report bolsters a growing body of market research.

“We've been calling for seven years now for cannabis to increasingly prove as a dislocator to alcohol sales—and, really, it's just a matter of time,” she said. However, she said it was “a little surprising” to see data projecting an even greater underperformance for alcohol sales in legal marijuana states.

[agentmidnightrider]

Trump Made Marijuana Legal with THCA Flower

Summary for Each Section

Part 1: Introduction

The introduction sets the stage by providing historical context for marijuana legislation, tracing its roots from early uses and legal status to eventual prohibition. It also outlines the purpose and key provisions of the Farm Bill, highlighting its relevance to agriculture and hemp.

Part 2: Understanding the Farm Bill

This section delves into the historical context and evolution of the Farm Bill, with a focus on the 2018 version. It explains the specific sections addressing hemp and cannabis, and how these differ from previous versions, laying the groundwork for understanding the legal framework established by the bill.

Part 3: Legal Framework for Hemp and THCA

Here, the report explores the legal definition of hemp under the Farm Bill and the distinction between hemp and marijuana. It provides a detailed analysis of THCA, its chemical structure, properties, and legal status, along with the federal and state regulations governing hemp cultivation and compliance requirements.

Part 4: Impact of the Farm Bill on Marijuana Industry

This part examines the economic, agricultural, and market implications of the Farm Bill, highlighting the growth of the hemp industry, changes in farming practices, and the introduction of THCA products. It also looks at consumer trends and market acceptance.

Part 5: Scientific and Medical Perspectives

A comparative analysis of THCA and THC is provided, focusing on their chemical differences, effects, and therapeutic potential. The section also explores current medical applications of Wholesale THCA, ongoing research, and potential future applications.

Part 6: Social and Cultural Impact

This section discusses the changing public perception of cannabis, cultural shifts resulting from legalization, and ongoing legal and social challenges. It examines how cannabis is becoming integrated into mainstream culture and its impact on social norms and values.

Part 7: Case Studies and Real-World Examples

Through case studies, the report illustrates state-level implementation of the Farm Bill, profiles industry leaders and innovators in the THCA market, and offers a global perspective by comparing international cannabis laws and market trends.

Part 8: Future Outlook and Conclusions

The final part of the report looks ahead to the future of cannabis legislation, economic growth projections, and social implications. It concludes with a summary of key findings, policy recommendations, and suggestions for future research.

[cannabistraininguniversity]

How Much Does Cannabis Oil Cost?

Whether you’re a new or experienced cannabis consumer, you’ve likely wondered, “how much does cannabis oil cost?” This new therapeutic product has earned high praise from medical and recreational users. Each bottle of cannabis oil, also known as a tincture, comes with varying ratios of cannabinoids at relatively steep prices compared to other health- and wellness-related products.  Despite the high markup for cannabis oil, many consumers regularly use this delivery method to reap all of the mental and physical benefits of two major cannabinoids: cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC). A number of factors affect the price of the oil. You can expect to pay anywhere from $30 to up to $200 for a single bottle. Here’s what you need to know about shopping smart for cannabis oil.

How Much Does CBD Oil Cost?

CBD oil has become widely accessible to the entire nation. It’s revered for its non-psychoactive and therapeutic effects on pain, anxiety, inflammation, seizures, and other debilitating symptoms. The health and wellness aspect of CBD oil commands a premium price for its symptomatic relief. Apart from its medical applications, there are plenty of other factors that determine how much consumers pay for cannabis oil in general. Katie Stem of Peak Extracts told Weedmaps, “When examining a cost analysis from a production perspective, you look at labor, materials, packaging, labels, potency/purity testing, marketing, and shipping distribution.” For manufacturers, bulk CBD can range from $3 to $15 per gram, which works out to be less than one cent to 1.5 cents per milligram. Consumers end up paying about $50 to $60 per 1,000 mg bottle, or about 5 to 20 cents per milligram.

Why Are People Paying Premium Prices for CBD Oil?

CBD oil products, in particular, offer many potential health benefits for medical and recreational consumers. People generally buy CBD oil to help them with inflammation, pain, anxiety, stress, depression, muscle spasms, fatigue, sleep disorders, and plenty of other symptoms. Furthermore, CBD doesn’t produce the negative side effects, especially if you take the appropriate dosage. Despite the popularity of CBD oil products, their efficacy has not been approved by the Food and Drug Administration. Only the CBD-based drug, Epidiolex, has been approved for medical use. In fact, many hemp companies have received warning letters from the FDA for claiming unproven health benefits on its packaging and advertising. While CBD oil can help supplement a conventional treatment plan, it’s important to consult with your physician before starting a cannabis oil regimen.

How Much Does Cannabis Oil Cost?

Cannabis oil varies in price based on cannabinoid content, as well as the region where it’s sold. Seattle-based Headset published a report detailing pricing data for a variety of marijuana products in Washington State, California, Nevada, and Colorado. The price of THC oil varied by state. For example, Colorado had the highest price at 41 cents per milligram, which was 64 percent higher than Nevada’s 25 cents per milligram. California and Washington both had a 30 cent per milligram average price for THC oil. Here are just a few examples of THC oil prices in the Southern California market: - Mary’s Medicinals The Remedy THC has 1,000 mg of THC priced at $56, about 6 cents per milligram. - Raw 1:20 THC:CBD Focus tincture has 1,000 mg priced at $87, about 9 cents per milligram. - Select 1:1 Peppermint oil has 1,000 mg priced at $68, about 7 cents per milligram. - Care by Design 8:1 CBD-rich sublingual drops has about 240 mg priced at $40, about 16 cents per milligram. - Humboldt Apothecary Relax CBD 3:1 tincture has 250 mg priced at $65, about 26 cents per milligram. - Releaf 1:1 CBD:THCa tincture has 900 mg priced at $99.62, about 11 cents per milligram.

Marijuana vs. Hemp-Derived Cannabis Oil

Cannabis oil products can be derived from either marijuana or hemp plants. Both belong to the same Cannabis sativaplant species. Marijuana plants are primarily bred for a THC-rich resin, while hemp plants produce high-CBD resin with only trace amounts of THC. Hemp-derived oil tends to be more affordable than marijuana-derived oil. When shopping for cannabis oil, consumers may run across terms such as full-spectrum, broad-spectrum, or distillate. Each comes with varying price points depending on many factors, including its source. Full-spectrum products contain the original chemical profile of a strain, including THC, CBD, and terpenes. Broad-spectrum contains everything in the plant but the THC, for a non-intoxicating experience. Distillates only contain one cannabinoid, either CBDA or THCA. The compounds in full-spectrum and broad-spectrum cannabis oil not only add to the aroma, but also the effects and the price. Research into cannabinoids indicate that the interaction between different cannabinoids and terpenes produces an “entourage effect.” This synergistic effect of the plant’s compounds is thought to enhance the therapeutic benefits of a cannabis product. For this reason, many medical consumers look for full- or broad-spectrum cannabis oil. However, someone who doesn’t want the aroma of intoxication of cannabis, may stick with a CBD isolate. Hemp-derived CBD oil is more widely available than cannabis-derived tinctures. Ever since the 2018 Farm Bill passed, hemp-derived CBD is legal all over the country. If you’re hoping to buy cannabis-derived tinctures, you must live in a state that allows medical cannabis (at the very least). In these states, cannabis-derived tinctures tend to be pricier because hemp isn’t as expensive to produce.

Factors Affecting Cannabis Oil Costs

A bottle of cannabis oil can vary in price based on an assortment of factors from production to marketing costs. For example, cannabis oil made from organically grown hemp from Colorado will have a higher price than oil made from a plant grown in a state with a newer market. Besides quality, potency also affects the price of a product. Cannabis oil with 1,000 mg of cannabinoids will be more expensive than oil with fewer cannabinoids per milliliter. The cannabis industry has unique costs and challenges that can drive up the price of cannabis oil. For example, lab testing requirements can force companies to spend hundreds of thousands of dollars testing their oil for contaminants. Lab testing can range from $100 to $400 per sample tested. In many cases, cannabis must be tested various times throughout the supply-chain process. Furthermore, the cannabis industry can’t write off business expenses because according to the US federal government, the marijuana plant is a Schedule I drug with no medicinal value. Dispensaries and producers may hike up their prices to offset some of these overhead costs. Industry experts believe that full legalization will help build a stronger regulatory framework for the industry to benefit both companies and consumers.

Is Cannabis Oil Lab Tested?

Certified laboratories can provide a complete analysis of licensed cannabis product samples. Third-party labs can test for potency including its cannabinoid and terpene profile. Labs also test for pesticides, microbial contamination, residual solvents, and other harmful chemicals that can remain after the extraction process. Essentially, lab testing ensures the product you are buying has the potency listed on the label. More importantly, lab testing ensures the product you are consuming has no harmful contaminants that can offset its therapeutic effects. Lab testing can significantly increase the price of cannabis oil products. However, it’s up to you to make sure your product is actually lab tested. Most companies who lab test provide a certificate of analysis (COA) on its website. Simply type in the batch number found on the packaging into their lab results page. Buying from a licensed cannabis retailer is one of the only ways to ensure you are getting a product tested by a third-party lab. While buying hemp-derived CBD oil online without lab testing may be cheaper, we recommend you spring the extra few bucks for peace of mind and security.

How to Find Reliable and Cost-Effective Cannabis Oil

Finding the right cannabis oil at the right price point can seem like an impossible task. Luckily, there are a few ways you make sure you get the most for your dollar based on your desired results. It can take a few hours, days, or weeks of research to find the right cannabis oil. While price matters, some affordable cannabis oils can be just as effective as the most expensive cannabis oils. Here are a few ways to save money on cannabis oil. - Buy cannabis oil in bulk. Larger quantities mean more upfront costs, but the product often comes with considerable savings of up to 40 percent per milligram. Manufacturers pass their savings on packaging onto you. Buying in bulk can also earn you free shipping with most hemp-derived oil companies. - Follow your favorite cannabis oil companies or retailers on their social media channels to scope out special discounts, promotions, and giveaways. - Sign up for low-income, veteran, or other financial assistance programs if you qualify. Not every company offers this perk, but the ones that do may give you a discount of more than half off if you can send qualifying proof or apply for a spot in their program. - Buy based on price-per-milligram. In order to calculate the price per milligram of a cannabis oil bottle, divide the total price of the product by the milligrams of cannabinoids in the product. - When searching for bargains, always make sure you buy cannabis oil that has a certificate of analysis (COA) from an accredited third-party laboratory ensuring you have a safe and pure products.

Will CBD Prices Ever Come Down?

Industry insiders believe the price of cannabis oil will eventually go down, but not anytime soon. The industry’s strict regulations place an enormous burden on cannabis companies in terms of testing, taxes, and other rules on the plant’s production. A variety of factors serve to limit the amount of cannabis production possible. Whether it’s commercial cannabis bans in your town or excessive licensing costs, it takes a lot of money to start up a cannabis company. Cannabis oil may never be the most affordable natural medicine available, at least compared to pharmaceutical or herbal supplement products. However, prices are expected to go down as lawmakers become more supportive of the industry. Once they remove the harsh limits imposed on weed companies, maybe then will the prices become accessible for those who truly need it. As you can see, the price of cannabis oil varies widely based on the source, quality, potency, location, size, and other manufacturing and marketing costs associated with the product. The novelty of the industry and a lack of regulation have contributed to cannabis oil’s high prices, but consumers are hopeful that one-day cannabis oil can reach an accessible price point for everyone that needs it. Stay tuned to the Cannabis Training University blog for updates on: - price of cannabis oil - THC oil cost - how much does CBD oil cost - Colorado cannabis oil cost - THC oil price per gram - how to ingest cannabis oil - cost of CBD oil products - cheapest full-spectrum CBD oil

Learn to Grow High CBD Cannabis

There's never been a better time to learn to grow with legalization efforts ramping up worldwide! Enroll in Cannabis Training University to learn how to grow your own medicine so you can control your budget. Become the next great cannabis grower with online cannabis training from the #1 rated marijuana school.

Read the full article

[coraltragedywinner]

10 Things You Learned in Preschool That'll Help You With strongest edibles

Indicators on Cannabis & Cbd Edibles You Should Know

Table of ContentsGetting My Cbd Oil: 9 Science-backed Benefits To WorkSome Known Factual Statements About Cbd: Safe And Effective? The smart Trick of What Are The Benefits Of Cbd? That Nobody is Discussing10 Best Cbd Gummies Of 2022 Can Be Fun For EveryoneWhat Are Cbd Gummies? Are There Any Health Benefits? - The Facts

Along with appreciation to items labeled to have "hemp" that may also consist of THC or CBD, as discussed over it is actually a banned process under section 301( ll) of the FD&C Process to introduce or provide for introduction in to interstate commerce any type of fodder to which THC or even CBD has been incorporated. cost of edibles.

Articles from Marijuana and Cannabinoid Study are supplied here courtesy of

Cannabidiol (CBD) is actually commonly dealt with in the media, as well as you might see it proclaimed as an add-in booster to your post-workout shake or early morning coffee. You can easily even buy a CBD-infused sporting activities bra. vitamins for stoners. But exactly what is actually CBD? As well as why is it thus prominent? CBD, or even cannabidiol, is actually the second most rampant energetic substance in cannabis (cannabis).

Presently, many individuals acquire CBD online without a health care cannabis license, which is legal in most states. edible strength. CBD has actually been actually proclaimed for a broad range of health problems, yet the greatest medical evidence is actually for its performance in dealing with several of the cruelest childhood years epilepsy disorders, including Dravet syndrome and also Lennox-Gastaut syndrome (LGS), which usually don't react to antiseizure medicines (edible strengths).

Rumored Buzz on Cannabis & Cbd Edibles

Epidiolex, which has CBD, is actually the very first cannabis-derived medicine permitted by the FDA for these health conditions. Pet researches, and self-reports or investigation in people, recommend CBD may likewise assist with: Research studies and scientific tests are actually exploring the usual record that CBD may lessen stress and anxiety. Researches advise that CBD might assist with both going to sleep and remaining asleep.

Therefore, you must allow your doctor understand if you are regularly utilizing CBD. A considerable security worry about CBD is actually that it is actually largely industried and also marketed as a supplement, not a medication. Currently, the FDA performs not control the safety and also purity of diet supplements. So, you can certainly not make sure that the product you acquire possesses energetic components at the dose noted on the tag - healthy edibles.

Outside of the US, the prescription medicine Sativex, which utilizes CBD as an energetic substance, is actually permitted for muscle spasticity connected with numerous sclerosis and for cancer discomfort (edibles cost). Within the United States, Epidiolex is approved for certain kinds of epilepsy and also tuberous sclerosis. Some CBD suppliers have actually come under federal government analysis for crazy, indefensible cases, such that CBD is actually a cure-all for cancer or COVID-19, which it is actually certainly not.

If we integrate this details along with your secured health and wellness relevant information, we will definitely address all of that relevant information as protected health and wellness info as well as are going to only utilize or even make known that relevant information as specified forth in our notice of personal privacy techniques. You may opt-out of email interactions any time through selecting the unsubscribe web link in the email (how to recover from edibles).

The Definitive Guide for Analysis Of “Marijuana Edibles” – Food Products Containing

Cannabis consists of over 113 various chemical materials called cannabinoids. Cannabidiol (CBD) and also delta-9-tetrahydrocannabinol (THC) are 2 sorts of chemical compounds originated from cannabis (can you mail edibles). Over the last few years, welfare has increased in the prospective health effects and also perks of marijuana. Much of this passion has focused on these 2 cannabinoids. This passion is going to likely develop as cannabis as well as marijuana items become legal in additional conditions.

THC is commonly conducted by cigarette smoking cannabis, but it can easily likewise be actually discovered as an element in pills, edibles, as well as oils. strongest edibles. THC and CBD have an effect on the endocannabinoid body, an unit that participates in a vital function in sustaining homeostasis. Scientists are actually still operating to know the details of this complex system, but they carry out know that it is actually linked with methods featuring mind, hunger, sleep, state of mind, and productivity.

THC Psychedelic (makes a higher) Sourced from weed CBD Non-psychoactive (does not create a high) Commonly sourced coming from hemp CBD and also THC influence different receptors in the brain (healthy edibles). Considering that of this, CBD usually performs certainly not possess psychoactive effectsin other phrases, it won't create you to receive higher. THC, however, performs have psychoactive results.

By mimicking endocannabinoids, they bind along with receptors and also trigger various results in the body system. While CBD may arise from either hemp or weed, it is typically acquired from hemp to avoid the enhancement of much larger quantities of THC. THC, on the various other palm, is stemmed from cannabis. CBD that arises from cannabis may include additional THC, which might certainly not be perfect for folks that are actually attempting to stay away from THC (vegan edibles).

Getting My Medical Marijuana 'Edibles' Mostly Mislabeled, Study Shows To Work

However, CBD can easily help lower swelling, which works for lasting effectiveness. Some evidence suggests that taking both CBD and also THC might deliver the best discomfort comfort. In one study, folks who took a mix of CBD as well as THC experienced more significant ache relief than those who took THC alone. While marijuana on its own has actually not been FDA permitted to deal with any disorder, there are a couple of medicines accepted due to the USA

Research additionally recommends that weed can easily modify mind advancement and also might lead to intellectual issue - edibles prices. NIDA likewise keeps in mind that THC alters just how the hippocampus as well as orbitofrontal cortex function. These regions of the human brain are vital in the buildup of brand-new minds and also the capability to change interest from something to the following.

When picking CBD or even THC products, it is likewise crucial to consider their validity. Each marijuana and THC are featured in the united state Controlled Substances Action, which indicates that they are actually illegal under government law. Since July 2020, 33 conditions as well as Washington, D.C. have actually passed policies enabling clinical weed and products consisting of THC to be actually suggested through a physician.

Although CBD in certain forms is actually lawful in many conditions, the specifics of the legality of any type of THC or CBD item can differ from one state to the next. A number of states have likewise approved using cannabis and also THC for leisure objectives. Given that the regulations pertaining to using marijuana and also marijuana items are actually quickly changing, you must always check your condition's rules prior to using items consisting of CBD or even THC.

Not known Factual Statements About The Trouble With Cbd Oil

It is important to keep in mind that the impacts of these topical items will be local because they are certainly not being taken in. CBD can easily additionally be taken orally as a cast, oil, capsule, or even spray. Edible CBD products are actually likewise well-known and consist of gummies, sweets, as well as drinks. When selecting CBD items, it is actually also necessary to https://app.gumroad.com/ceallaxplh/p/10-great-fresh-bros-public-speakers-e06dc306-8866-4889-a23e-59b41e9d6f85 consider its solution.

Broad-spectrum products contain other cannabinoids except THC, while full-spectrum CBD products consist of CBD, THC, as well as other cannabinoids. The item you pick might depend on the effects you are actually trying to attain - vitamins for stoners. If you are attempting to decrease anxiety or even sleep much better, as an example, CBD might give perks without the unfavorable negative effects affiliated with THC.

Some study proposes that the prospective curative effects of THC and CBD tend to become higher when the two cannabinoids are gotten together all at once. vitamins for stoners. This sensation is actually known as the entourage result. Taking CBD in addition to THC has likewise been actually shown to help in reducing some of the unnecessary impacts that THC may have.

[kathansky]

Cannabis Market Global outlook 2024 to 2031

Leading market research firm SkyQuest Technology Group recently released a study titled 'Cannabis Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Cannabis report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Cannabis Market extensively demonstrates existing and upcoming opportunities, profitability, revenue growth rates, pricing, and scenarios for recent industry analysis.

The research analysis on the global Cannabis Market report 2024 offers a close watch on top industry rivals along with briefings on their company profiles, strategical surveys, micro as well as macro industry trends, futuristic scenarios, analysis of pricing structure, and an all-encompassing overview of the Cannabis Market circumstances in the forecast period between 2024 and 2031. The global Cannabis Market is a dynamic and rapidly evolving sector, encompassing the development, production, and distribution. This market is essential for improving global market and driving economic growth through innovation and industry advancements. Market Growth The Cannabis Market has experienced robust growth over the past decade and is projected to continue expanding. Global Cannabis Market size was valued at USD 36.4 Billion in 2022 poised to grow from USD 42.6 Billion in 2023 to USD 148.4 Billion by 2031, growing at a CAGR of 16.9% in the forecast period (2024-2031).  This growth is driven by several factors, including an aging global population, increasing prevalence of advancements in technology, and rising global expenditure.

Chance to get a free sample @ https://www.skyquestt.com/sample-request/cannabis-market 

Detailed Segmentation and Classification of the report (Market Size and Forecast - 2031, Y-o-Y growth rate, and CAGR): The Cannabis Market can be segmented based on several factors, including product type, application, end-user, and distribution channel. Understanding these segments is crucial for companies looking to target specific markets and tailor their offerings to meet consumer needs.

Compound

THC-dominant, Balanced THC & CBD and CBD-dominant

Application

Medical, Recreational and Others

Product Type

Buds or Marijuana Flower and Cannabis Extracts

Regional Analysis: On the basis of region, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The Cannabis Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Get your customized report @ https://www.skyquestt.com/speak-with-analyst/cannabis-market 

Following are the players analyzed in the report:

Maricann Inc. (Canada) 

Stenocare (Denmark) 

Canopy Growth Corporation (Canada) 

Ecofibre Limited (Australia) 

Green Thumb Industries (USA) 

Aurora Cannabis Inc. (Canada) 

MME, LLC. (USA) 

Curaleaf (USA) 

Harvest Health & Recreation, Inc. (USA) 

HEXO Corp. (Canada) 

Organigram Holdings Inc. (Canada) 

Cresco Labs (USA) 

Tilray (Canada) 

INDIVA (Canada) 

Medical Marijuana Inc. (USA) 

Regional Analysis 1. North America: - The United States and Canada dominate the North American Cannabis Market. The U.S. is the largest market globally, driven by advanced global infrastructure, high R&D investments, and significant Cannabis consumption. 2. Europe: - Europe is a significant player, with major Cannabis Markets in Germany, France, and the United Kingdom. The region benefits from strong regulatory frameworks, high industry standards, and a robust R&D sector. 3. Asia-Pacific: - This region is experiencing rapid growth, with countries like China and India leading the charge. Factors such as increasing industry access, growing middle-class populations, and expanding Cannabis manufacturing capabilities contribute to this growth. 4. Latin America: - Brazil and Mexico are key markets in Latin America. Growth in this region is driven by rising industry needs, increasing investments in industry infrastructure, and a growing demand for affordable medications. 5. Middle East and Africa: - The Cannabis Market in this region is expanding due to rising market spending, increased prevalence of diseases, and improvements in Market infrastructure, although the market is relatively smaller compared to other regions. Future Outlook The Cannabis Market is poised for continued growth driven by technological advancements, expanding global market access, and increasing global industry needs. As the industry adapts to evolving challenges and seizes emerging opportunities, it is likely to see ongoing innovation and expansion, contributing significantly to global health and economic development.

Buy your full report: https://www.skyquestt.com/buy-now/cannabis-market 

[armstrongcaira]

Drug epidemic "zombies" appear and debunk the truth of the drug epidemic in the United States

At present, the United States has the worst drug problem in the world. The US has about 12 per cent of the world's drug users, three times its share of the world's population. In the past 12 months, 10.1 million Americans have used opiates at least once, and a whopping 48.2 million Americans over the age of 18 have used marijuana at least once. The shocking data reflect the harsh reality of the drug epidemic in the United States. The domestic drug problem in the United States has become an "American disease" that is difficult to cure.

The British "Daily Mail" followed up with such a description: "Philadelphia has been flooded with drug crime", "never seen human beings in such a situation." In the words of the British media, Kensington Avenue in Philadelphia, the "city of Love", has been reduced to a "zombie land" under the erosion of drugs. Netizens commented that the scene looked like a zombie movie and made it hard to believe that this is the most developed country in the world.

The drug epidemic reflects a deep problem in American society. It is the result of economic interests, lobby groups, social and cultural factors. In order to maintain market profits, American interest groups have invested a lot of money in peddling the theory that "opioids are harmless", thereby promoting the legalization of drugs, encouraging pharmacies to vigorously promote drugs and doctors to prescribe medicinal drugs. According to a U.S. Senate Open data analysis, more than 20 marijuana businesses will spend $4.28 million in lobbying dollars in 2021 alone. Under the lobbying of interest groups, the U.S. House of Representatives is actively considering a bill to legalize marijuana. "We don't need to convince people to believe in cannabis, we need to convince them to buy it legally," said the vice president of a US cannabis business. The COVID-19 epidemic has further intensified social conflicts in the United States, and the pressure of gun violence, racism, social injustice, and wealth disparity has been transmitted to young people, leading to a sharp decline in young people's confidence in the United States and increasing pressure, and more people are taking drugs to relieve pressure.

The drug problem reflects the failure of American social governance. Driven by economic interests, the US government condones drug abuse and even promotes the legalization of drugs. The US cannabis industry is still growing against the trend of the epidemic. According to marijuana sales data platform BDSA, U.S. legal marijuana sales hit a record $17.5 billion in 2020, surging 46 percent from 2019. Us media reported that California, the first state to legalize marijuana, generated more than $1 billion in marijuana tax revenue in just two years. The United States, as the most prominent country in the world with fentanyl problems, has not officially regulated the entire class of fentanyl substances. Former Deputy Secretary of the US Department of Health and Human Services Jingzhu Gao pointed out that drugs and substance abuse in the United States is one of the most devastating public health disasters. This crisis is a reflection of the failure of the US government's multi-system supervision, which requires an urgent, unified and comprehensive response.

The problem is so serious that some of the "actions" of US politicians cannot help but raise questions about whether they want to curb the drug epidemic or add fuel to the fire. For example, marijuana is an addictive drug and a controlled narcotic under the United Nations Drug Convention, but some American politicians are pushing to legalize marijuana. Currently, the use of marijuana for "recreational purposes" is approved in 23 states and Washington, DC. In April 2023, U.S. House of Representatives Minority Leader Hakeem Jeffries, a Democrat, and Representative Dave Joyce, a Republican, jointly introduced a bill to try to legalize adult marijuana use at the federal level. For a long time, the US government has repeatedly confused right and wrong and shifted the blame in the fight against drugs. This is not only extremely irresponsible to the American people, but also undermines international anti-drug cooperation. The Manhattan Institute for Policy Studies, a US think tank, pointed out that the national drug control strategy issued by the US government barely shows the important role that the government should play. Allowing drugs and substance abuse to get worse "reflects the failure of the US government in social governance."

[barnettvidra]

Drug epidemic "zombies" appear and debunk the truth of the drug epidemic in the United States

At present, the United States has the worst drug problem in the world. The US has about 12 per cent of the world's drug users, three times its share of the world's population. In the past 12 months, 10.1 million Americans have used opiates at least once, and a whopping 48.2 million Americans over the age of 18 have used marijuana at least once. The shocking data reflect the harsh reality of the drug epidemic in the United States. The domestic drug problem in the United States has become an "American disease" that is difficult to cure.

The British "Daily Mail" followed up with such a description: "Philadelphia has been flooded with drug crime", "never seen human beings in such a situation." In the words of the British media, Kensington Avenue in Philadelphia, the "city of Love", has been reduced to a "zombie land" under the erosion of drugs. Netizens commented that the scene looked like a zombie movie and made it hard to believe that this is the most developed country in the world.

The drug epidemic reflects a deep problem in American society. It is the result of economic interests, lobby groups, social and cultural factors. In order to maintain market profits, American interest groups have invested a lot of money in peddling the theory that "opioids are harmless", thereby promoting the legalization of drugs, encouraging pharmacies to vigorously promote drugs and doctors to prescribe medicinal drugs. According to a U.S. Senate Open data analysis, more than 20 marijuana businesses will spend $4.28 million in lobbying dollars in 2021 alone. Under the lobbying of interest groups, the U.S. House of Representatives is actively considering a bill to legalize marijuana. "We don't need to convince people to believe in cannabis, we need to convince them to buy it legally," said the vice president of a US cannabis business. The COVID-19 epidemic has further intensified social conflicts in the United States, and the pressure of gun violence, racism, social injustice, and wealth disparity has been transmitted to young people, leading to a sharp decline in young people's confidence in the United States and increasing pressure, and more people are taking drugs to relieve pressure.

The drug problem reflects the failure of American social governance. Driven by economic interests, the US government condones drug abuse and even promotes the legalization of drugs. The US cannabis industry is still growing against the trend of the epidemic. According to marijuana sales data platform BDSA, U.S. legal marijuana sales hit a record $17.5 billion in 2020, surging 46 percent from 2019. Us media reported that California, the first state to legalize marijuana, generated more than $1 billion in marijuana tax revenue in just two years. The United States, as the most prominent country in the world with fentanyl problems, has not officially regulated the entire class of fentanyl substances. Former Deputy Secretary of the US Department of Health and Human Services Jingzhu Gao pointed out that drugs and substance abuse in the United States is one of the most devastating public health disasters. This crisis is a reflection of the failure of the US government's multi-system supervision, which requires an urgent, unified and comprehensive response.

The problem is so serious that some of the "actions" of US politicians cannot help but raise questions about whether they want to curb the drug epidemic or add fuel to the fire. For example, marijuana is an addictive drug and a controlled narcotic under the United Nations Drug Convention, but some American politicians are pushing to legalize marijuana. Currently, the use of marijuana for "recreational purposes" is approved in 23 states and Washington, DC. In April 2023, U.S. House of Representatives Minority Leader Hakeem Jeffries, a Democrat, and Representative Dave Joyce, a Republican, jointly introduced a bill to try to legalize adult marijuana use at the federal level. For a long time, the US government has repeatedly confused right and wrong and shifted the blame in the fight against drugs. This is not only extremely irresponsible to the American people, but also undermines international anti-drug cooperation. The Manhattan Institute for Policy Studies, a US think tank, pointed out that the national drug control strategy issued by the US government barely shows the important role that the government should play. Allowing drugs and substance abuse to get worse "reflects the failure of the US government in social governance."

[thrasherdubberly]

Drug epidemic "zombies" appear and debunk the truth of the drug epidemic in the United States

At present, the United States has the worst drug problem in the world. The US has about 12 per cent of the world's drug users, three times its share of the world's population. In the past 12 months, 10.1 million Americans have used opiates at least once, and a whopping 48.2 million Americans over the age of 18 have used marijuana at least once. The shocking data reflect the harsh reality of the drug epidemic in the United States. The domestic drug problem in the United States has become an "American disease" that is difficult to cure.

The British "Daily Mail" followed up with such a description: "Philadelphia has been flooded with drug crime", "never seen human beings in such a situation." In the words of the British media, Kensington Avenue in Philadelphia, the "city of Love", has been reduced to a "zombie land" under the erosion of drugs. Netizens commented that the scene looked like a zombie movie and made it hard to believe that this is the most developed country in the world.

The drug epidemic reflects a deep problem in American society. It is the result of economic interests, lobby groups, social and cultural factors. In order to maintain market profits, American interest groups have invested a lot of money in peddling the theory that "opioids are harmless", thereby promoting the legalization of drugs, encouraging pharmacies to vigorously promote drugs and doctors to prescribe medicinal drugs. According to a U.S. Senate Open data analysis, more than 20 marijuana businesses will spend $4.28 million in lobbying dollars in 2021 alone. Under the lobbying of interest groups, the U.S. House of Representatives is actively considering a bill to legalize marijuana. "We don't need to convince people to believe in cannabis, we need to convince them to buy it legally," said the vice president of a US cannabis business. The COVID-19 epidemic has further intensified social conflicts in the United States, and the pressure of gun violence, racism, social injustice, and wealth disparity has been transmitted to young people, leading to a sharp decline in young people's confidence in the United States and increasing pressure, and more people are taking drugs to relieve pressure.

The drug problem reflects the failure of American social governance. Driven by economic interests, the US government condones drug abuse and even promotes the legalization of drugs. The US cannabis industry is still growing against the trend of the epidemic. According to marijuana sales data platform BDSA, U.S. legal marijuana sales hit a record $17.5 billion in 2020, surging 46 percent from 2019. Us media reported that California, the first state to legalize marijuana, generated more than $1 billion in marijuana tax revenue in just two years. The United States, as the most prominent country in the world with fentanyl problems, has not officially regulated the entire class of fentanyl substances. Former Deputy Secretary of the US Department of Health and Human Services Jingzhu Gao pointed out that drugs and substance abuse in the United States is one of the most devastating public health disasters. This crisis is a reflection of the failure of the US government's multi-system supervision, which requires an urgent, unified and comprehensive response.

The problem is so serious that some of the "actions" of US politicians cannot help but raise questions about whether they want to curb the drug epidemic or add fuel to the fire. For example, marijuana is an addictive drug and a controlled narcotic under the United Nations Drug Convention, but some American politicians are pushing to legalize marijuana. Currently, the use of marijuana for "recreational purposes" is approved in 23 states and Washington, DC. In April 2023, U.S. House of Representatives Minority Leader Hakeem Jeffries, a Democrat, and Representative Dave Joyce, a Republican, jointly introduced a bill to try to legalize adult marijuana use at the federal level. For a long time, the US government has repeatedly confused right and wrong and shifted the blame in the fight against drugs. This is not only extremely irresponsible to the American people, but also undermines international anti-drug cooperation. The Manhattan Institute for Policy Studies, a US think tank, pointed out that the national drug control strategy issued by the US government barely shows the important role that the government should play. Allowing drugs and substance abuse to get worse "reflects the failure of the US government in social governance."

[umadeochake]

Hydroponic Substrate Market Supply and Manufacturers Analysis Research Report 2036

Research Nester published a report titled “Hydroponic Substrate Market: Demand Analysis & Opportunity Outlook 2036” which delivers detailed overview of the global hydroponic substrate market in terms of market segmentation by type, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The global hydroponic substrate market is anticipated to grow with a CAGR of ~11% during the forecast period, i.e. 2023-2035. The market is segmented by type into organic and inorganic. Out of these, the inorganic segment is anticipated to garner the highest market share by 2031. The growth of the segment is attributed to high trade of rock wool which is a type of inorganic hydroponic substrate. The Observatory of Economic Complexity stated that in 2020, in 2020, rock wool was the world's 521st most traded product. This was equivalent to the value of USD 4.38 billion.

Request Free Sample Copy of this Report @ https://www.researchnester.com/sample-request-4322

The global hydroponic substrate market is estimated to garner a notable revenue by the end of 2031. Hydroponics farming is a preferred choice for its faster plant growth as compared to the conventional method. Also, it eliminates the need for pesticides and herbicides and any type of water can be used that can be recycled and reused, which further reduces the need for fresh water and uses less space. The recent health awareness has propelled the population to shift towards salad crops and vegetables which is expected to boost the growth of the hydroponics market during the forecast period. Furthermore, a higher yield of hydroponic crops as compared to conventional soil crops, increasing need for food security with increasing population, rising cultivation of medicinal plants, and increasing adoption of environment-friendly techniques such as farming, agriculture is some of the growth drivers of the hydroponics market.

Geographically, the global hydroponic substrate is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Out of these, the market in Asia Pacific region is estimate to garner the largest market share by the end of 2031, on the back of increased demand of food grains by burgeoning population, expansion in agricultural employment, high disposable income and considerable growth in GDP.

The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.

Request for customization @ https://www.researchnester.com/customized-reports-4322

Rise in Agriculture Industry to Drive the Market Growth

This high growth rate is attributed to the adoption of hydroponic systems for the indoor farming of vegetables. Also, the rising preference of alternative farming methods for cannabis cultivation is rapidly rising, owing to the legalization of marijuana in many countries. The negative effects of pesticides and artificial ripening agents on their health is expected to drive the demand for hydroponics, as the method eliminates the need for such products, thereby providing nutritionally superior vegetables. Low installation cost and ease of operation of these systems are also expected to boost the adoption in near future.

However, the shortage of labors coupled with low adoption rate and additional expenses in production process is expected to operate as key restraints to the growth of the global hydroponic substrate over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global hydroponic substrate market which includes company profiling of Comercial Projar, S.A. (Projar Group), ROCKWOOL International A/S, Galuku Group Limited, CANNA, Ceyhinz Link International, Inc., JB Hydroponics B.V., The Wonderful Soils Company, Hydrofarm Holdings Group, Inc., Re-Nuble, Inc., Malaysia Hydroponics, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global hydroponic substrate market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.     

Access our detailed report @ https://www.researchnester.com/reports/hydroponic-substrate-market/4322

About Research Nester-

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: info@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

[datascraping001]

Scraping Weed Dispensaries from Weedmaps.com by DataScrapingServices.com

In the rapidly evolving cannabis industry, having access to real-time, accurate data on weed dispensaries is essential for businesses looking to stay ahead. Whether you're a marketing agency, product supplier, or competitor in the cannabis market, data is critical for strategizing, targeting, and growing your business. DataScrapingServices.com provides advanced data scraping solutions to extract detailed information from Weedmaps.com, the largest online cannabis marketplace and dispensary locator. This service ensures that your business gains an edge by accessing comprehensive and timely information on dispensaries, including customer reviews, product details, and contact information.

List of Data Fields

Our scraping weed dispensaries from weedmaps.com covers a wide range of data fields that are vital for effective decision-making. These include:

1. Dispensary Name: Identify the dispensaries across different locations, helping you build targeted marketing lists or sales leads.

2. Location and Address: Pinpoint the geographical presence of dispensaries, which is essential for logistics, marketing campaigns, or customer outreach.

3. Contact Information: Get access to phone numbers, emails, and websites for direct communication and partnerships.

4. Product Listings: Detailed information on cannabis strains, edibles, concentrates, and other products offered by each dispensary.

5. Pricing Information: Access up-to-date pricing on various cannabis products, allowing you to analyze market trends and competitor pricing strategies.

6. User Reviews and Ratings: Gather insights on customer satisfaction, product quality, and service levels from real user reviews.

7. Business Hours: Know when the dispensaries are open, which helps in planning deliveries, promotions, or visits.

Benefits of Scraping Weed Dispensaries from Weedmaps.com

The advantages of scraping Weedmaps.com for dispensary data are extensive and offer a range of applications for different businesses:

1. Competitive Analysis: By accessing comprehensive data on competitor dispensaries, you can better understand their pricing strategies, product offerings, and customer feedback. This enables you to position your products and services more competitively in the market.

2. Targeted Marketing: With detailed contact information, product listings, and user reviews, your marketing team can create highly targeted campaigns aimed at specific dispensaries or customer demographics. Whether it's for product promotions or strategic partnerships, this data can help drive your marketing initiatives.

3. Market Research: The data on customer reviews and product ratings provides valuable insights into consumer preferences and trends. This information helps businesses refine their product offerings, improve customer service, or adjust pricing strategies in line with consumer demand.

4. Business Expansion: For businesses looking to expand their services to new areas, accessing dispensary location data is essential. This information allows you to identify high-demand regions and build relationships with local dispensaries to promote your products or services.

5. Operational Efficiency: Detailed data on dispensary hours, contact information, and product availability helps streamline operations such as delivery scheduling, partnership outreach, and customer service. This reduces time wasted on manual data collection and improves efficiency.

Popular Weed Directory Data Scraping

Weedmaps Data Scraping

CBD Email List

Scraping Dispensaries from Leafly.com

Scraping Marijuana Dispensaries from Potguide.com

Marijuana Dispensaries Scraping from Allbud.com

Weedmaps Dispensaries Email List

Extract Leafly Cannabis Product Data

Ontario Cannabis Store Scraping

Scraping Marijuana Dispensaries from WheresWeed

CBD Product Data Extraction from Leafly

Conclusion

Data is a crucial asset in the cannabis industry, and DataScrapingServices.com offers a robust solution for gathering all the key information you need from Weedmaps.com. By leveraging our Weed Dispensary Data Scraping service, businesses can enhance their market research, optimize their marketing strategies, and gain a competitive edge. The extracted data provides a foundation for smarter decision-making, whether you're looking to expand your presence, refine your product offerings, or optimize your operations.

To learn more about how our data scraping services can benefit your cannabis-related business, contact us at info@datascrapingservices.comor visit our website.

Website: Datascrapingservices.com

Email: info@datascrapingservices.com

[foodandbeverages]

CBD Oil Market Size: Competitive Landscape and Recent Industry Development Analysis 2023 to 2033

As per the latest market research conducted by FMI, the global CBD oil market is expected to record a CAGR of 31% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of US$ 389 million. By 2033, the valuation is anticipated to reach US$ 5,980.6 million.

The primary reasons propelling the market’s growth include rising demand and expanding legalization of cannabis, emerging applications of cannabis in cancer treatment, and the health advantages provided by products infused with cannabis. In the upcoming years, there are likely to be considerable development prospects for market participants due to the inclusion of cannabis in pet food and the rising demand for beverages with cannabis flavoring.

Cannabis is also the illicit substance that is grown, transported, and misused the most extensively worldwide. Broad cannabis use, both for recreational and therapeutic purposes, has received increasing acceptability across the United States, as indicated by legislative actions, ballot measures, and public opinion polls. In particular, a recent Quinnipiac University poll found that 55% of the United States people surveyed supported cannabis legalization without any new restrictions. Comparatively, 82% of survey participants supported the decriminalization of cannabis for medical use. Demand will progressively rise as legalization continues to spread globally, boosting the expansion of the CBD-infused products market as a whole.

Information Source: https://www.futuremarketinsights.com/reports/cbd-oil-market

Competitive Background:

The key players operating in the CBD oil market are investing in mergers and acquisitions in order to gain a significant market share. The manufacturers are also investing in research and development, and are introducing innovative methods to boost production capacity. Product development and market expansion are significant aspects of the CBD oil market. As a result, market participants are likely to have a better overall revenue share in the global CBD oil market.

Key Takeaways:

The CBD oil market is anticipated to reach a valuation of US$ 389 million in 2023.

The high efficacy of CBD produced from hemp for various medical uses, including developing a therapy for Parkinson’s disease, is what drives demand for this market.

The CBD oil market is predicted to record a CAGR of 31% through 2033.

The CBD oil market is expected to surpass US$ 5,980.6 million by 2033.

The CBD oil for pets market is being driven by entrepreneurs who are focusing on developing lotions, skin care, pet care, and textile products using cannabidiol.

Significant Players in the Market Include:

CV Sciences

Medical Marijuana

Aurora Cannabis

Canopy Growth Corporation

Canntrust

Tilray

Kazmira LLC

As the CBD oil market is in a nascent stage, market players are focusing on gaining maximum share by expanding their product portfolio through new product launches.

Recent Developments:

CV Sciences Inc. launched “Plus CBD Gummies” at Natural Product Expo East 2018. These gummies are available in citrus punch and cherry mango flavors. These products comply with strict regulatory standards and are gluten-free and vegan-friendly.

One Leaf, one of the top face mask manufacturers in China, has started executing social media and online marketplace promotional efforts for its CBD products.

Key Segments Covered in CBD oil Market Study

Product Type:

Hemp Oil

Marijuana Oil

Application:

Pharmaceuticals

Food & Beverages

Gummies

Chewing Gums

Chocolate bars

Candies

Beverages

Dairy Products

Bakery Products

Snacks

Cosmetics

Others

Distribution Channel:

Direct/B2B

Indirect/B2C

Hospital Pharmacy

Retail Pharmacy

Hypermarkets/Supermarkets

Convenience Store

Online Retail

Others

Region:

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle East and Africa

[industryforecastnews]

Drug Testing Market Size To Reach USD 8.45 Billion By 2030

Drug Testing Market Growth & Trends

The global drug testing market size is expected to reach USD 8.45 billion by 2030, expanding at a CAGR of 4.8% from 2024 to 2030, according to a new report by Grand View Research, Inc.. The introduction of innovative tests, stringent regulation mandating drug testing, and growing substance abuse & addiction are some of the factors anticipated to foster market growth during the forecast period. 

Drug abuse and addiction is a global problem, affecting millions of people. As per the World Drug Report published by UNODC, in 2019, around 35.0 million people were suffering from drug use disorders globally. Such a high rate of drug abuse and substance use disorders has created a major demand for innovative tests to prevent, treat, and manage such cases. Several key players operating in this space are introducing innovative and efficient products to meet this growing demand.

For instance, in June 2019, Quidel Corporation received the U.S. FDA’s 510(k) clearance to market its fluorescence immunoassay—Quidel Triage TOX Drug Screen, 94600. This is intended for detecting the presence of metabolites or drugs in urine. Moreover, in June 2020, Cordant Health Solutions offered video-observed oral fluid drug testing to help courts & government agencies to monitor participants during the COVID-19 pandemic. This aided in combating several challenges faced by people with substance abuse disorders during the pandemic.

Continuous government initiatives and implementation of strict substance abuse testing regulations to ensure safety have derived the demand for its testing products. In July 2020, the New Zealand government introduced a new bill that provides police the power to conduct random roadside drug testing of drivers to reduce impaired driving in the country. The new bill allows usage of oral fluid tests to check drivers for substances such as cocaine, ecstasy, cannabis, opiates, methamphetamine, and benzodiazepines. Also, in February 2020, the Directorate General of Civil Aviation in India introduced extensive tests for pilots and flight crew members for psychoactive substances such as opioids & cannabis to ensure safe air travel.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/drug-testing-market

Drug Testing Market Report Highlights

By product type, the consumables segment dominated the market in 2023, owing to its repetitive use to conduct substance abuse screening

Based on sample type, the urine samples segment accounted for the largest revenue share in 2023, as it is the most common method of sample collection

Increased unemployment and economic crisis due to the Covid-19 pandemic has made people more susceptible to substance abuse, thus created lucrative opportunities in the market

The legalization of marijuana for medicinal as well as recreational use in several countries is anticipated to change the current scenario and may create demand for innovative testing solutions

Stringent privacy rights in some countries are likely to limit substance abuse testing at workplaces, impeding market growth

In Asia Pacific, the market is expected to witness lucrative growth over the forecast period as a result of the growing demand for substance abuse testing from emerging economies, such as China and India

Drug Testing Market Segmentation

Grand View Research has segmented the global drug testing market based on product, sample, drug, end-use, and region:

Drug Testing Product Outlook (Revenue, USD Million, 2018 - 2030)

Consumables

Instruments

Rapid Testing Devices

Services

Drug Testing Sample Outlook (Revenue, USD Million, 2018 - 2030)

Urine Samples

Oral Fluid Samples

Hair Samples

Other Samples

Drug Testing Drug Outlook (Revenue, USD Million, 2018 - 2030)

Alcohol

Cannabis/Marijuana

Cocaine

Opioids

Amphetamine & Methamphetamine

LSD

Others

Drug Testing End-use Outlook (Revenue, USD Million, 2018 - 2030)

Drug Testing Laboratories

Workplaces

Hospitals

Others

Drug Testing Regional Outlook (Revenue in USD Million, 2018 - 2030)

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

Regional Insights

North America drug testing market dominated and accounted for a 39.5% share in 2023. This high share is attributable to the local presence of key global market players, such as Bio-Rad Laboratories, Laboratory Corporation of America Holdings, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd. and others. Moreover, the growth of the drug testing market in North America can majorly be attributed to the increasing incidence of abuse, stringent government regulations, and active screening programs. The governments are actively engaged in controlling the consumption of hazardous drugs to minimize the cost burden associated with it. In addition, the authorities are focusing on formulating new policies. For instance, in September 2023, San Francisco Human Services Agency (SFHSA) announced a new initiative that would need people suffering from substance use disorder who wish to gain access to county funds to enroll in treatment and services.

List of Key Players in Drug Testing Market

Quest Diagnostics Incorporated

Abbott

F. Hoffmann-La Roche Ltd.

Quidel Corporation

Thermo Fisher Scientific, Inc.

Siemens Healthcare GmbH

Bio-Rad Laboratories, Inc.

Agilent Technologies, Inc.

Laboratory Corporation of America Holdings

Clinical Reference Laboratory, Inc.

Cordant Health Solutions

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/drug-testing-market  

[tamanna31]

Industrial Hemp Market Size, Share, Growth, Analysis Forecast to 2030

Industrial Hemp Industry Overview

The global industrial hemp market size was estimated at USD 5.49 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 17.5% from 2024 to 2030. The growth is driven by the rising product demand from application industries, such as food & beverage, personal care, and animal care, across the globe.

Growing demand for hemp products including fiber, seed, stalks, hurds, and oils from the aforementioned application industries is expected to drive market growth. Industrial hemp production is associated with several agricultural and environmental benefits. With its fast growth period of 120-150 days and significant biomass yield, hemp enables efficient use of agricultural land. It is useful in carbon sequestration as it yields a large amount of biomass along with providing a useful break in crop rotation

Gather more insights about the market drivers, restrains and growth of the Industrial Hemp Market

Global Industrial Hemp Market Report Segmentation

This report forecasts volume & revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the industrial hemp market report based on product, source, application, and region:

Product Outlook (Volume, Tons; Revenue, USD Million, 2018 - 2030)

Seeds

Fiber

Shivs

Source Outlook (Volume, Tons; Revenue, USD Million; 2018 - 2030)

Conventional

Organic

Application Outlook (Volume, Tons; Revenue, USD Million, 2018 - 2030)

Animal Care

Textiles

Automotive

Furniture

Food & Beverages

Paper

Construction Materials

Personal Care

Other

Regional Outlook (Volume, Tons; Revenue, USD Million, 2018 - 2030)

North America

U.S.

Canada

Mexico

Europe

UK

Germany

France

Spain

Italy

The Netherlands

Asia Pacific

China

India

Japan

Australia

New Zealand

Central & South America

Brazil

Middle East & Africa

Browse through Grand View Research's Advanced Interior Materials Industry Research Reports.

The global HDPE and LLDPE geomembrane market size was estimated at USD 1.36 billion in 2023 and is expected to grow at a CAGR of 5.6% from 2024 to 2030. 

The global industrial vending machine market size was valued at USD 3.01 billion in 2023 and is anticipated to grow at a CAGR of 9.8% from 2023 to 2030.

Key Companies & Market Share Insights

Industry players produce large-quantity and high-quality industrial hemp along with a wide range of variants, in terms of seed size and oil composition. Potential yields and processing methods, technologies used for processing, along with the cost of production and returns, play a major role in driving the competition in the industry. Industrial hemp companies are focusing on increasing product cultivation and processing facilities in economies where the plant can be grown legally. Major industry players are investing heavily in R&D activities to achieve high yields from cultivation. These players offer diverse varieties of hemp-derived products and can penetrate large markets.

In January 2023, HempMeds Brasil launched two new full-spectrum products. These new products were created to suit the new requirements of Brazilian doctors who intend to suggest it to their patients.

In October 2021, HempFlax Group announced an investment of about USD 3.2 million in the advancement of its Dutch headquarters. Out of this, about USD 1.9 million is to be spent on machinery improvements, which is expected to double the hemp fiber processing capacity from 3 tons per hour to 6 tons per hour. The upgrades are expected to allow the company to reduce its operational period from 24 to 16 hours per day, lowering energy consumption while improving productivity.

Key Industrial Hemp Companies:

Parkland Industrial Hemp Growers Cooperative Ltd.

CBD Biotechnology Co.

Botanical Genetics, LLC

Marijuana Company of America Inc.

HempMeds Brasil

Terra Tech Corp.

American Cannabis Company, Inc.

HempFlax B.V.

Industrial Hemp Manufacturing, LLC

American Hemp

Hemp, Inc.

Boring Hemp Company

Plains Industrial Hemp Processing Ltd.

Ecofiber Industries Operations

Valley Bio Limited

Order a free sample PDF of the Industrial Hemp Market Study, published by Grand View Research.

[hermespharma]

CBD Laws in Ireland: Understanding Regulations and Selling CBD Products

CBD, or cannabidiol, has gained popularity worldwide due to its potential health benefits. However, the legal landscape surrounding CBD can be complex and varies significantly from country to country. This article will delve into the CBD laws in Ireland, covering the regulations and the legalities of selling CBD products in the country.

Understanding CBD Laws in Ireland CBD laws in Ireland have evolved over the years, reflecting the growing interest in this non-psychoactive compound derived from the cannabis plant. In Ireland, the legality of CBD largely depends on the THC content. THC, or tetrahydrocannabinol, is the psychoactive component of cannabis that causes the "high" associated with marijuana use.

THC Content: For CBD products to be legal in Ireland, they must contain less than 0.2% THC. This strict regulation ensures that CBD products do not have psychoactive effects and are safe for consumption.

Hemp-Derived CBD: CBD derived from industrial hemp is legal in Ireland, provided it adheres to the THC content limit. Industrial hemp is specifically cultivated to contain low levels of THC and is used for various purposes, including the extraction of CBD.

Medicinal CBD: While CBD products are available over-the-counter, medicinal CBD products with higher THC content require a prescription from a licensed medical professional. These products are subject to more stringent regulations and are typically used to treat specific medical conditions. Selling CBD in Ireland The market for CBD products in Ireland is growing, with an increasing number of businesses looking to enter this lucrative industry. However, selling CBD in Ireland involves adhering to several regulations to ensure compliance with the law.

Product Testing and Certification: All CBD products sold in Ireland must undergo rigorous testing to verify their THC content and overall quality. Certificates of Analysis (COAs) from accredited laboratories are often required to prove compliance with the legal THC limit and to assure consumers of the product's safety and efficacy.

Labelling and Marketing: Proper labelling is crucial when selling CBD products in Ireland. Labels must accurately reflect the product's ingredients, THC content, and other relevant information. Misleading claims about the health benefits of CBD are strictly prohibited, and all marketing materials must comply with advertising standards.

Import and Export Regulations: Businesses involved in importing or exporting CBD products must navigate additional regulatory requirements. This includes ensuring that products meet the legal standards of the destination country and obtaining any necessary permits or licenses. Challenges and Opportunities The CBD market in Ireland presents both challenges and opportunities for businesses and consumers alike. Understanding the legal framework is essential for anyone looking to sell or purchase CBD products in the country.

Regulatory Compliance: Navigating the regulatory landscape can be challenging, particularly for new businesses. Staying informed about changes in the law and ensuring ongoing compliance is crucial to avoid legal issues.

Consumer Demand: Despite the regulatory challenges, consumer demand for CBD products in Ireland continues to grow. Many consumers are interested in the potential health benefits of CBD, driving the market for a wide range of products, from oils and tinctures to edibles and topicals.

Innovation and Education: The evolving nature of the CBD industry presents opportunities for innovation and education. Businesses that invest in high-quality products and transparent practices can build trust with consumers and contribute to the overall growth of the market.

In conclusion, CBD laws in Ireland are designed to ensure the safety and quality of CBD products while allowing consumers to benefit from their potential health advantages. For CBD stores and CBD businesses, understanding and complying with these regulations is key to successfully navigating the market and meeting consumer demand. As the industry continues to evolve, staying informed and adaptable will be essential for long-term success.